http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090040404-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a0ef8d0df08d96c7bcd2403b3f8d83b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee84c3a0a558df893be4b91f134c270d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4253eba6f9fbd7b5e5c4e4d6b12d3e09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ce561a3520db7adea53a64fda5ca4a1 |
| publicationDate | 2009-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20090040404-A |
| titleOfInvention | Use of antisecretory factors for the treatment of ocular hypertension |
| abstract | The present invention relates to the use of antisecretory factors such as antisecretory proteins, homologues having antisecretory activity, homologues, derivatives and / or fragments thereof for the preparation of pharmaceutical compositions for the treatment and / or prophylaxis of ocular hypertension. Accordingly, the present invention is directed to the use of a pharmaceutical composition comprising an antisecretory factor in the treatment and / or prophylaxis of ocular hypertension, which is preferably characterized by obstructed bodily fluid outflow resulting in elevated intraocular pressure. The present invention provides a novel method for treating and / or preventing such symptoms comprising changing the intraocular pressure to an acceptable level, up to 21 mmHg. |
| priorityDate | 2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 283.